In October 2012 Cochrane Collaboration researcher Tom Jefferson made a maladministration complaint to the European Ombudsman. In his letter, displayed below, he says the European Medicines Agency issued a market authorisation for oseltamivir on 20 June 2002. The EMA do not have and have never had a complete evidence set, he says.
Displaying 1-1 out of 1 published














Total cost of overdiagnosis is probably 50 times higher than modelled here
Published 21 May 2013
Re: Antibiotics for back pain: hope or hype?
Published 21 May 2013
Re: Are antidepressants overprescribed? No
Published 21 May 2013
UGC India and MCI should lower the beam for a while for teachers in FAMILY MEDICINE, to let it come up as a different entity taught by specialists from FAMILY MEDICINE only
Published 21 May 2013